Is Atorvastatin Associated with New Onset Diabetes or Deterioration of Glycemic Control? Systematic Review Using Data from 1.9 Million Patients
Background. Current evidence indicates that statins increase the risk of new onset diabetes mellitus (NOD) and also deteriorate the glycemic control in patients with known diabetes mellitus (DM) after high-dose statin therapy. Aims. The aim of this review was to explore the effect of atorvastatin in...
Saved in:
| Main Authors: | Angeliki M. Angelidi, Emelina Stambolliu, Konstantina I. Adamopoulou, Antonis A. Kousoulis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2018/8380192 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic evaluation of inclisiran on the risk of new-onset diabetes and hyperglycemia compared to evolocumab and atorvastatin
by: Fei Li, et al.
Published: (2025-07-01) -
A Palpable Painless Axillary Mass as the Clinical Manifestation of Castleman’s Disease in a Patient with Hepatitis C Disease
by: Athanasia K. Papazafiropoulou, et al.
Published: (2016-01-01) -
Joint Effects of Physical Activity and Body Mass Index on Prevalent Diabetes in a Nationally Representative Sample of 1.9 Million US Adults
by: David Abernethy, et al.
Published: (2025-01-01) -
Onset of strong Iceland-Scotland overflow water 3.6 million years ago
by: Matthias Sinnesael, et al.
Published: (2025-05-01) -
Glycemic and non-glycemic benefits of initial triple therapy versus sequential add-on therapy in patients with new-onset diabetes: results from the EDICT study
by: JOHN ADAMS, et al.
Published: (2025-04-01)